Lloyds Banking Lifts 2023 Interest Margin, Returns Guidance; 2Q Pretax Profit Missed Views
By Elena Vardon
Lloyds Banking Group on Wednesday posted pretax profit for the second quarter of 2023 below expectations but lifted some of its guidance for the year.
The British bank posted a pretax profit for the three months to June 30 of 1.61 billion pounds ($2.08 billion) compared with GBP1.54 billion restated for the same period a year earlier and with GBP1.72 billion expected by a company-compiled consensus.
The FTSE 100 listed group's net income rose to GBP4.53 billion from a restated GBP4.03 billion, beating a consensus estimate of GBP4.51 billion. Its banking net interest margin was 3.14% for the quarter, while consensus had seen it at 3.10%.
The lender lifted its banking net interest margin guidance for the year to 3.10%, from 3.05% previously, but below consensus of 3.12% for 2023. Lloyds also now sees its return on tangible equity to be greater than 14%, from around 13%, while consensus forecasts 14.5%.
It closed the period with a common equity Tier 1 ratio--a key measure of balance-sheet strength--of 14.2%, in line with market expectations.
The board proposed an interim dividend of 0.92 pence in line with views, compared with 0.80 pence last year.
Write to Elena Vardon at elena.vardon@wsj.com
(END) Dow Jones Newswires
July 26, 2023 02:44 ET (06:44 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Boeing Stock a Buy, a Sell, or Fairly Valued?
-
The 10 Best Companies to Invest in Now